Clinical Trial Update: Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease [Phase 3]

View source ↗

Summary

Miglustat was evaluated in a Phase 3 long-term study for efficacy, safety, and tolerability in patients with stable Gaucher disease type 1. The trial completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease Type

Drugs mentioned

• Miglustat (miglustat)

Snippet

Sponsor: Actelion | Conditions: Gaucher Disease Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2012-05-23